Works matching AU Berends, Cecile L.

Results: 4
    1

    A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.

    Published in:
    Pharmacology Research & Perspectives, 2021, v. 9, n. 2, p. 1, doi. 10.1002/prp2.739
    By:
    • Berends, Cécile L.;
    • Pagan, Lisa;
    • van Esdonk, Michiel J.;
    • Klarenbeek, Naomi B.;
    • Bergmann, Kirsten R.;
    • Moerland, Matthijs;
    • der Wel, Vincent van;
    • de Visser, Saco J.;
    • Büller, Hans;
    • Loos, Frans de;
    • de Vries, Wouter S.;
    • Waals, Hans;
    • de Leede, Leo G. J.;
    • Burggraaf, Jacobus;
    • Kamerling, Ingrid M. C.
    Publication type:
    Article
    2

    Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID‐19: A phase 2a, open‐label, single‐dose escalation study.

    Published in:
    British Journal of Clinical Pharmacology, 2023, v. 89, n. 3, p. 1105, doi. 10.1111/bcp.15560
    By:
    • Prins, Manon L. M.;
    • van der Plas, Johan L.;
    • Vissers, Maurits F. J. M.;
    • Berends, Cécile L.;
    • Tresch, Gaby;
    • Soergel, Marianne;
    • Fernández, Elena;
    • van den Berge, Nikita;
    • Duijsings, Daniël;
    • Zitt, Christof;
    • Stavropoulou, Vaia;
    • Zimmermann, Maya;
    • Drake, Roxana F.;
    • Burggraaf, Jacobus;
    • Groeneveld, Geert H.;
    • Kamerling, Ingrid M. C.
    Publication type:
    Article
    3

    First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management.

    Published in:
    British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 103, doi. 10.1111/bcp.14931
    By:
    • Moss, Laurence M.;
    • Berends, Cecile L.;
    • van Brummelen, Emilie M. J.;
    • Kamerling, Ingrid M. C.;
    • Klaassen, Erica S.;
    • Bergmann, Kirsten;
    • Ville, Vanessa;
    • Juarez‐Perez, Victor;
    • Benichou, Annie‐Claude;
    • Groeneveld, Geert Jan
    Publication type:
    Article
    4

    Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement.

    Published in:
    British Journal of Clinical Pharmacology, 2021, v. 87, n. 12, p. 4658, doi. 10.1111/bcp.14884
    By:
    • Mellion, Michelle L.;
    • Ronco, Lucienne;
    • Berends, Cecile L.;
    • Pagan, Lisa;
    • Brooks, Sander;
    • van Esdonk, Michiel J.;
    • van Brummelen, Emilie M. J.;
    • Odueyungbo, Adefowope;
    • Thompson, Lorin A.;
    • Hage, Michelle;
    • Badrising, Umesh A.;
    • Raines, Shane;
    • Tracewell, William G.;
    • van Engelen, Baziel;
    • Cadavid, Diego;
    • Groeneveld, Geert J.
    Publication type:
    Article